Notice of NIDDK’s Intent to Withdraw from PA-06-413

Notice Number: NOT-DK-07-001

Key Dates
Release Date: January 23, 2007

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov)

The National Institute of Diabetes and Digestive Diseases (NIDDK) announces that it is terminating its participation in PA-06-413: Diet, Epigenetic Events, and Cancer Prevention (R21).

The NIDDK is participating in the NIH Exploratory/Developmental Research Grant Program (Parent R21) which may be found at http://grants.nih.gov/grants/guide/pa-files/PA-06-181.html. Information about NIDDK’s R21 program can be found at http://www2.niddk.nih.gov/Funding/Grants/ApplicantGuidelines/R21.htm .

The following Institutes continue to participate in PA-06-413:

National Cancer Institute (NCI), (http://www.nci.nih.gov)
National Institute of Alcohol Abuse and Alcoholism (NIAAA), (http://www.niaaa.nih.gov)
Office of Dietary Supplements (ODS), (http://dietary-supplements.info.nih.gov/)

Inquiries
For questions regarding this specific NIDDK notice please contact:

Michael K. May, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
6707 Democracy Boulevard, 2 Democracy Plaza Room 663, MSC 5450
Bethesda, MD 20892-5450 (for U.S. Postal Service express or regular mail)

Bethesda, MD 20817 (for express/courier delivery)
Telephone: 301-594-8884
Fax: 301-480-8300
Email: maym@mail.nih.gov